WATCHMAN™ For Professionals
The Region’s Only Provider of the WATCHMAN™ Left Atrial Appendage Closure Device Procedure.
The Heart Hospital’s Structural Heart Program is pleased to offer the implant-based WATCHMAN™ Left Atrial Appendage (LAA) Closure Device procedure. This minimally invasive procedure provides an alternative treatment to long-term anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation.
Indications For Use
The WATCHMAN™ Device is indicated to reduce the risk of thromboembolism from the LAA in patients with non-valvular atrial fibrillation who:
Are at an increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2- VASc scores and are recommended for anticoagulation therapy,
Are deemed to be suitable for short-term (at least 45 days), but not long-term, warfarin therapy, and
Have an appropriate rationale to seek a nonpharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device compared to warfarin.
What To Expect
Implantation is performed as an inpatient procedure and under general anesthesia.
It takes about an hour to complete the procedure, which requires transfemoral access and transseptal puncture.
The patient requires an overnight stay in the hospital (24 hours), and follow-up office visits are required.
Following the procedure, the patient stays on warfarin for a minimum of 45 days (until endotheliazation of the device).
When warfarin ceases, clopidogrel is initiated for six months, and the patient remains on aspirin indefinitely.
Download the WATCHMAN™ Information Flyer
Our Expert Physician Team
The Heart Hospital’s WATCHMAN ™ implant team includes echocardiographers, interventional cardiologists, cardiac electrophysiologists, cardiac surgeons and anesthesiologists. If you have questions, call our structural heart coordinator, Cynthia Ansbro at 812-842-4509
For additional materials and information visit - Boston Scientific WATCHMAN